BlackRock Fund Advisors - ACTINIUM PHARMACEUTICALS INC ownership

ACTINIUM PHARMACEUTICALS INC's ticker is ATNM and the CUSIP is 00507W107. A total of 24 filers reported holding ACTINIUM PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BlackRock Fund Advisors ownership history of ACTINIUM PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2016$92,000
-32.8%
104,967
+3.1%
0.00%
Q3 2016$137,000
-24.3%
101,851
-0.1%
0.00%
Q2 2016$181,000
+17.5%
102,003
+31.5%
0.00%
Q1 2016$154,000
-42.8%
77,550
-6.9%
0.00%
Q4 2015$269,000
+92.1%
83,298
+5.0%
0.00%
Q3 2015$140,000
-35.2%
79,303
-2.6%
0.00%
Q2 2015$216,000
-86.3%
81,397
-87.2%
0.00%
Q1 2015$1,572,000
-54.6%
636,400
+8.2%
0.00%
-100.0%
Q4 2014$3,463,000
+3.3%
587,940
+17.5%
0.00%0.0%
Q3 2014$3,353,000
-4.7%
500,395
+2.7%
0.00%0.0%
Q2 2014$3,519,000487,4620.00%
Other shareholders
ACTINIUM PHARMACEUTICALS INC shareholders Q4 2015
NameSharesValueWeighting ↓
Sio Capital Management, LLC 339,796$163,0000.04%
Malaga Cove Capital, LLC 30,000$14,0000.01%
Summit X, LLC 35,000$16,0000.01%
ARDSLEY ADVISORY PARTNERS LP 75,000$36,0000.01%
INTRUST BANK NA 40,000$19,0000.01%
Fosun International Ltd 168,851$78,0000.01%
Truvestments Capital LLC 11,648$6,0000.01%
DLD Asset Management, LP 140,660$68,0000.00%
Hartford Financial Management Inc. 18,000$9,0000.00%
SNS Financial Group, LLC 26,000$12,0000.00%
View complete list of ACTINIUM PHARMACEUTICALS INC shareholders